Search for: "Boehringer Ingelheim Pharma GMBH"
Results 1 - 20
of 25
Sorted by Relevance
|
Sort by Date
26 Oct 2021, 12:41 am
On 8 October 2021, His Honour Judge Hacon (sitting as a Judge of the High Court) handed down his decision in an action brought by Royalty Pharma Collection Trust (“Royalty Pharma”) for approximately €23 million in royalty payments from Boehringer Ingelheim GmbH (“Boehringer”) (Royalty Pharma Collection Trust v Boehringer Ingelheim GmbH [2021] EWHC 2692 (Pat)). [read post]
9 Aug 2009, 4:54 pm
Boehringer Ingelheim Pharma GmbH & Co. [read post]
15 Jul 2007, 6:11 pm
Boehringer Ingelheim Pharma GmbH Co. [read post]
13 Feb 2014, 6:00 am
District Court Judge David Herndon from the Southern District of Illinois imposed close to $1 million in punitive damages on defendants Boehringer Ingelheim International GMBH (“BII”) and Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
5 May 2010, 4:46 am
Aurobindo Pharma Ltd. et al. [read post]
10 Mar 2010, 5:22 am
(FDA Law Blog) US: Review and correction of patent term adjustment calculation made by the USPTO: Boehringer Ingelheim Pharma GmbH & Co. [read post]
10 Mar 2010, 5:22 am
(FDA Law Blog) US: Review and correction of patent term adjustment calculation made by the USPTO: Boehringer Ingelheim Pharma GmbH & Co. [read post]
9 Jan 2009, 3:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
6 Feb 2009, 5:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
27 May 2010, 3:20 am
Boehringer Ingelheim International GMBH et al. [read post]
21 Dec 2016, 12:48 am
These are the issues considered by the Court of Appeal in last week's decision concerning an application for permission to appeal in Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG [2016] EWCA Civ 1296. [read post]
12 Mar 2015, 11:09 am
Today's the day that many pharmaceutical patent term extension-watchers have been waiting for with feelings of optimism or anxiety: the day on which the Court of Justice of the European Union (CJEU) delivered its ruling in Case C‑577/13, Actavis Group PTC EHF, Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. [read post]
13 May 2010, 4:58 pm
(FDA Law Blog) US: Divisional of a divisional: Avoid terminal disclaimers: CAFC denies en banc rehearing in Boehringer Ingelheim International GMBH v. [read post]
16 Mar 2015, 3:10 am
CJEU rules in telmisartan SPC disputeAfter his own earlier post on the CJEU’s decision in Case C‑577/13, Actavis Group PTC EHF, Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. [read post]
25 Aug 2009, 1:30 pm
Boehringer Ingelheim International GmbH v Commissioner of Patents [2001] FCA 647 and Prejay Holdings Ltd v Commissioner of Patents [2003] FCAFC 77 applied. [read post]
30 Dec 2009, 3:44 am
In this event Panels partially dismiss complaints to the extent that they include additional unrelated respondents, as in Boehringer Ingelheim Pharma GmbH & Co. [read post]
1 Dec 2009, 9:45 am
Intervet Inc. and Boehringer Ingelheim Vetmedica, Inc. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
31 Dec 2008, 2:35 pm
In Austria Paranova marketed genuine pharma products bearing the mark ZOVIRAX in packs of 60 x 400 mg tablets (ZOVIRAX 400/60), which were legitimately put on the market in the countries of the European Economic Area and which Paranova's parent company bought in the normal course of trade. [read post]
15 Nov 2016, 2:00 pm
Boehringer Ingelheim GMBH, 237F.3d 1359, 1365 (Fed. [read post]
